Scott Kamelle

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 391 citations · Full text

Predictors of Complications after Inguinal Lymphadenectomy

Natalie Gould, Scott Kamelle, Todd Tillmanns et al. · Gynecologic Oncology · 2001 · 173 citations

Surgical Oncology, Outcomes Research, Thoracic Surgery +5

A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer

M. Patrick Lowe, Donald H. Chamberlain, Scott Kamelle et al. · Gynecologic Oncology · 2009 · 130 citations

Gynecologic Surgery, Surgical Oncology, Gynecological Surgery +12

A Multiinstitutional Experience With Robotic-Assisted Hysterectomy With Staging for Endometrial Cancer

M. Patrick Lowe, Peter R. Johnson, Scott Kamelle et al. · Obstetrics and Gynecology · 2009 · 107 citations